5 AMA PRA Category 1 Credits™

AMS – 2019IMhe-Internal Medicine – Hematology: Venous Thromboembolism; Anemia; Coagulopathy

$119.00$189.00

$119.00
$189.00
StreamingINCLUDED FREE

Topics and Objectives

Title: Internal Medicine – Hematology: Venous Thromboembolism; Anemia; Coagulopathy

Faculty: Kevin S. Ferentz, M.D., Joel Kravitz, M.D., F.A.C.E.P., F.R.C.P.S.C., Herbert L. Muncie, Jr. M.D.

Original Release Date: July 1, 2019  Expiration Date: July 1, 2022

TOPIC 1: Venous Thromboembolism (VTE): Diagnosis and Treatment.

Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to: COMP, GL, EBM

  1. Determine the diagnostic testing for evaluating a patient for possible VTE.
  2. Apply the algorithm for diagnosing a pulmonary embolism in multiple clinical settings.
  3. Differentiate the advantages and disadvantages of outpatient treatment compared to inpatient treatment for venous thromboembolism (VTE).
  4. Order the frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE.

TOPIC 2: Anemia.

Upon completion of this session, the participant should be able to: COMP, GL

  1. Develop a diagnostic strategy to ascertain the etiology of the anemia.
  2. Utilize the guidelines for diagnosing anemia in children and adults in terms of available testing.
  3. Develop a clinical approach to treating various anemias to include Iron Deficiency and “Anemia of Chronic Disease” due to infections, inflammatory dz’s, CKD, Malignancies, Cytokines, Interferons, TNF’s, etc.
  4. Describe the role of consultants in the evaluation and management of anemia.

TOPIC 3: Coagulopathy in the ER: All Bleeding Stops Eventually.

Upon completion of this session, the participant should be able to: COMP, EBM

  1. Differentiate different patterns of coagulopathy that present to the ED.
  2. Develop an evaluation and treatment plan for non-traumatic bleeding disorders in the ED, including hemophilia, TTP, ITP and others.
  3. Outline the rationale and indications for the use of blood products used in the treatment of the bleeding patient.
  4. Discuss some of the newer anticoagulation agents used today, such as Prasugrel (Effient) and Dabigatran (Pradaxa), as per thr referenced RCT’s and EBM studies such as Rocket, RE-LY and Einstein.


Total Cost: $

Title: Internal Medicine – Hematology: Venous Thromboembolism; Anemia; Coagulopathy

Faculty: Kevin S. Ferentz, M.D., Joel Kravitz, M.D., F.A.C.E.P., F.R.C.P.S.C., Herbert L. Muncie, Jr. M.D.

Original Release Date: July 1, 2019  Expiration Date: July 1, 2022

TOPIC 1: Venous Thromboembolism (VTE): Diagnosis and Treatment.

Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to: COMP, GL, EBM

  1. Determine the diagnostic testing for evaluating a patient for possible VTE.
  2. Apply the algorithm for diagnosing a pulmonary embolism in multiple clinical settings.
  3. Differentiate the advantages and disadvantages of outpatient treatment compared to inpatient treatment for venous thromboembolism (VTE).
  4. Order the frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE.

TOPIC 2: Anemia.

Upon completion of this session, the participant should be able to: COMP, GL

  1. Develop a diagnostic strategy to ascertain the etiology of the anemia.
  2. Utilize the guidelines for diagnosing anemia in children and adults in terms of available testing.
  3. Develop a clinical approach to treating various anemias to include Iron Deficiency and “Anemia of Chronic Disease” due to infections, inflammatory dz’s, CKD, Malignancies, Cytokines, Interferons, TNF’s, etc.
  4. Describe the role of consultants in the evaluation and management of anemia.

TOPIC 3: Coagulopathy in the ER: All Bleeding Stops Eventually.

Upon completion of this session, the participant should be able to: COMP, EBM

  1. Differentiate different patterns of coagulopathy that present to the ED.
  2. Develop an evaluation and treatment plan for non-traumatic bleeding disorders in the ED, including hemophilia, TTP, ITP and others.
  3. Outline the rationale and indications for the use of blood products used in the treatment of the bleeding patient.
  4. Discuss some of the newer anticoagulation agents used today, such as Prasugrel (Effient) and Dabigatran (Pradaxa), as per thr referenced RCT’s and EBM studies such as Rocket, RE-LY and Einstein.

Additional information

Format

Hardcopy, Download

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.